Sonova (OTCMKTS:SONVY) Hits New 1-Year High – Should You Buy?

Sonova Holding (OTCMKTS:SONVY) shares reached a new 52-week high on Monday. The company traded as high as $67.13 and last traded at $67.13, with a volume of 2,322 shares traded. The stock had previously closed at $66.33.

Analyst Ratings Changes

Several equities analysts recently commented on SONVY shares. UBS Group upgraded shares of Sonova from a “hold” rating to a “buy” rating in a research note on Wednesday, July 22nd. Morgan Stanley raised shares of Sonova from an “underweight” rating to an “equal weight” rating in a research report on Tuesday, June 23rd. The Goldman Sachs Group upgraded shares of Sonova from a “hold” rating to a “buy” rating in a research note on Thursday, October 8th. Finally, Citigroup reissued a “sell” rating on shares of Sonova in a report on Friday, July 24th. One equities research analyst has rated the stock with a Strong Buy rating, three have issued a Buy rating, two have issued a Hold rating and one has given a Sell rating to the company’s stock. According to data from MarketBeat.com, the company presently has a consensus rating of “Moderate Buy”.

Sonova Price Performance

The company has a debt-to-equity ratio of 0.51, a current ratio of 1.75 and a quick ratio of 1.43. The firm has a 50 day moving average of $59.75 and a 200-day moving average of $53.22.

Sonova Company Profile

Sonova Holding AG is a Switzerland-based hearing-care company that develops, manufactures and distributes solutions for people with hearing loss. Its portfolio includes hearing aids, cochlear implants, hearing implants, wireless communication products and related accessories and services.

The company markets products under several brands, including Phonak, Unitron and Advanced Bionics. Sonova also operates hearing-care businesses and retail networks that provide hearing assessments, device fitting, rehabilitation support and after-sales services.